In adolescents and Older people, Szefler et al showed which the addition of FeNO measurement being an indicator of bronchial asthma Management resulted in larger doses of ICS and very long-acting ?two agonists than did regular guideline-dependent treatment method, and didn't determine enhancements in bronchial asthma signs and symptoms or lung purp